Litigation Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
✉ Email this page to a colleague
Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-04-03 |
| Court | District Court, D. Delaware | Date Terminated | 2018-10-05 |
| Cause | no cause specified | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | MALLINCKRODT IP UNLIMITED COMPANY | ||
| Patents | 6,992,218; 9,399,012; 9,610,265 | ||
| Attorneys | Gregory Erich Stuhlman | ||
| Firms | Polsinelli PC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mallinckrodt IP v. B. Braun Medical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-06-09 | Approval of Braun's NDA with respect to U.S. Patent 6,992,218 to July 6, 2017 (answer complaint) and 30 …2017 5 October 2018 1:17-cv-00365 830 Patent None District Court, D. Delaware | External link to document | ||
| 2017-04-03 | 1 | Complaint | 6,992,218 (“the ’218 patent”) (collectively, the “patents-in-suit”). 2. Plaintiff Mallinckrodt… U.S. Patent No. 9,399,012 (“the ’012 patent”) and is the exclusive sub-licensee of U.S. Patent No. 6,992,218… action for infringement of the patents-in-suit pursuant to the Patent Laws of the United States, 35 …involves patents that are or were at issue in other actions before this Court. The ’218 patent was at … THE PATENTS-IN-SUIT 14. The ’218 patent, titled “Method for Obtaining | External link to document |
| 2017-06-06 | 11 | Stipulation to EXTEND Time | Approval of Braun's NDA with respect to U.S. Patent 6,992,218 to July 6, 2017 (answer complaint) and 30 …2017 5 October 2018 1:17-cv-00365 830 Patent None District Court, D. Delaware | External link to document |
| 2018-05-17 | 158 | Memorandum and Order | for infringement of U.S . Patent Nos. 6,992,218 (the '" 218 patent") and 9,399,012 (the…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent." …of the ' 012 patent and U.S . Patent No. 9,610,265 (the "' 265 patent"), is DENIED…discovery from SCR Pharmatop or the inventors on the patents-in-suit, the Court disagrees. 2. … standing, including unredacted versions of the Patent Assignment Agreement and the Asset Purchase Agreement | External link to document |
| 2018-06-05 | 167 | Opinion - Memorandum Opinion | to a Paragraph IV certification to U.S . Patent No. 6,992,218 from Defendant B. Braun Medical Inc. (&…012 patent and U.S. Patent No. 9,610,265 (collectively with the ' 012 and ' 218 patents, the…alleging infringement of the ' 218 patent and U.S . Patent No. 9,399,012. On May 31, 2017, in response…the "asserted patents"). The ' 218 patent is directed to the manufacture of aqueous formulations…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the | External link to document |
| 2017-04-03 | 4 | Patent/Trademark Report to Commissioner | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2; 6,992,218 B2. (nmg) (Entered…2017 5 October 2018 1:17-cv-00365 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
